Why the study?
Do pulmonary effective arterial elastance and pulmonary arterial compliance better predict mortality than pulmonary vascular resistance or transpulmonary gradient in patients with pulmonary hypertension due to left heart disease?
Do pulmonary effective arterial elastance and pulmonary arterial compliance better predict mortality than pulmonary vascular resistance or transpulmonary gradient in patients with pulmonary hypertension due to left heart disease?
Answers are grounded in this paper and cite their sources.
Pulmonary effective arterial elastance and pulmonary arterial compliance are superior prognostic markers for mortality compared to traditional measures like pulmonary vascular resistance in patients with pulmonary hypertension due to left heart disease.
Pulmonary Ea and pulmonary arterial compliance more consistently predicted mortality than pulmonary vascular resistance or transpulmonary gradient across a spectrum of left heart disease with pulmonary hypertension, including patients with heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, and pulmonary hypertension with a normal pulmonary vascular resistance.
No takes yet. Share an insight, caveat, or question.
Tampakakis et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: